- Home
- ACTU vs JHI Comparison
ACTU vs JHI Comparison
Compare ACTU & JHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- JHI
- Stock Information
- Founded
- ACTU 2015
- JHI 1971
- Country
- ACTU United States
- JHI United States
- Employees
- ACTU N/A
- JHI N/A
- Industry
- ACTU
- JHI Trusts Except Educational Religious and Charitable
- Sector
- ACTU
- JHI Finance
- Exchange
- ACTU NYSE
- JHI Nasdaq
- Market Cap
- ACTU 153.1M
- JHI 124.0M
- IPO Year
- ACTU 2024
- JHI N/A
- Fundamental
- Price
- ACTU $8.98
- JHI $14.11
- Analyst Decision
- ACTU
- JHI
- Analyst Count
- ACTU 0
- JHI 0
- Target Price
- ACTU N/A
- JHI N/A
- AVG Volume (30 Days)
- ACTU 59.7K
- JHI 29.5K
- Earning Date
- ACTU 11-13-2024
- JHI 01-01-0001
- Dividend Yield
- ACTU N/A
- JHI 6.80%
- EPS Growth
- ACTU N/A
- JHI N/A
- EPS
- ACTU N/A
- JHI 1.05
- Revenue
- ACTU N/A
- JHI N/A
- Revenue This Year
- ACTU N/A
- JHI N/A
- Revenue Next Year
- ACTU N/A
- JHI N/A
- P/E Ratio
- ACTU N/A
- JHI $12.47
- Revenue Growth
- ACTU N/A
- JHI N/A
- 52 Week Low
- ACTU $5.51
- JHI $11.63
- 52 Week High
- ACTU $10.16
- JHI $13.40
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- JHI 50.88
- Support Level
- ACTU N/A
- JHI $14.00
- Resistance Level
- ACTU N/A
- JHI $14.16
- Average True Range (ATR)
- ACTU 0.00
- JHI 0.11
- MACD
- ACTU 0.00
- JHI -0.01
- Stochastic Oscillator
- ACTU 0.00
- JHI 35.63
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.